QY Research > レポート一覧 > メディカルケア > セルフメディケーションによる投薬世界市場の発展状況と動向 2024-2030

セルフメディケーションによる投薬世界市場の発展状況と動向 2024-2030

英文タイトル: Global Self-Administered Medication Market Insights, Forecast to 2030

セルフメディケーションによる投薬世界市場の発展状況と動向 2024-2030
  • レポートID:275591
  • 発表時期:2024-04-25
  • 訪問回数:767
  • ページ数:111
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:132
  • レポートカテゴリ: メディカルケア

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書はセルフメディケーションによる投薬市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはセルフメディケーションによる投薬の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のセルフメディケーションによる投薬市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはセルフメディケーションによる投薬のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にセルフメディケーションによる投薬市場を分類しています。本研究に含まれる主な企業は:Pfizer、Abbott Laboratories、Novartis、Sanofi、BD、Takeda Pharmaceutical、Mylan、Amgen、Antares Pharma、Purdue Pharma

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
Oral
Subcutaneous
Nasal
Transdermal
Others

用途別の市場セグメント:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

レポートの詳細内容
世界のセルフメディケーションによる投薬市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、セルフメディケーションによる投薬タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のセルフメディケーションによる投薬収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のセルフメディケーションによる投薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、セルフメディケーションによる投薬市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

セルフメディケーションによる投薬のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:セルフメディケーションによる投薬のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:セルフメディケーションによる投薬の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3セルフメディケーションによる投薬企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:セルフメディケーションによる投薬の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:セルフメディケーションによる投薬の主要企業の概要を提供し、製品の説明と仕様、セルフメディケーションによる投薬の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient.
Market Analysis and Insights: Global Self-Administered Medication Market
The global Self-Administered Medication market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

By distribution channel, the hospital pharmacies segment is expected to represent significant revenue growth by the end of 2025. However, the online pharmacies distribution channel segment is expected to register a healthy CAGR during the forecast period.
Report Covers:
This report presents an overview of global market for Self-Administered Medication market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Self-Administered Medication, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Self-Administered Medication, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Self-Administered Medication revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Self-Administered Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Self-Administered Medication revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Abbott Laboratories, Novartis, Sanofi, BD, Takeda Pharmaceutical, Mylan, Amgen and Antares Pharma, etc.

Market Segmentation
By Company
    Pfizer
    Abbott Laboratories
    Novartis
    Sanofi
    BD
    Takeda Pharmaceutical
    Mylan
    Amgen
    Antares Pharma
    Purdue Pharma

Segment by Type
    Oral
    Subcutaneous
    Nasal
    Transdermal
    Others

Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Self-Administered Medication in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Self-Administered Medication companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Self-Administered Medication revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Self-Administered Medication Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Nasal
1.2.5 Transdermal
1.2.6 Others
1.3 Market by Application
1.3.1 Global Self-Administered Medication Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Self-Administered Medication Market Perspective (2019-2030)
2.2 Global Self-Administered Medication Growth Trends by Region
2.2.1 Self-Administered Medication Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Self-Administered Medication Historic Market Size by Region (2019-2024)
2.2.3 Self-Administered Medication Forecasted Market Size by Region (2025-2030)
2.3 Self-Administered Medication Market Dynamics
2.3.1 Self-Administered Medication Industry Trends
2.3.2 Self-Administered Medication Market Drivers
2.3.3 Self-Administered Medication Market Challenges
2.3.4 Self-Administered Medication Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Self-Administered Medication by Players
3.1.1 Global Self-Administered Medication Revenue by Players (2019-2024)
3.1.2 Global Self-Administered Medication Revenue Market Share by Players (2019-2024)
3.2 Global Self-Administered Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Self-Administered Medication, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Self-Administered Medication Market Concentration Ratio
3.4.1 Global Self-Administered Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Self-Administered Medication Revenue in 2023
3.5 Global Key Players of Self-Administered Medication Head office and Area Served
3.6 Global Key Players of Self-Administered Medication, Product and Application
3.7 Global Key Players of Self-Administered Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Self-Administered Medication Breakdown Data by Type
4.1 Global Self-Administered Medication Historic Market Size by Type (2019-2024)
4.2 Global Self-Administered Medication Forecasted Market Size by Type (2025-2030)

5 Self-Administered Medication Breakdown Data by Application
5.1 Global Self-Administered Medication Historic Market Size by Application (2019-2024)
5.2 Global Self-Administered Medication Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Self-Administered Medication Market Size (2019-2030)
6.2 North America Self-Administered Medication Market Size by Type
6.2.1 North America Self-Administered Medication Market Size by Type (2019-2024)
6.2.2 North America Self-Administered Medication Market Size by Type (2025-2030)
6.2.3 North America Self-Administered Medication Market Share by Type (2019-2030)
6.3 North America Self-Administered Medication Market Size by Application
6.3.1 North America Self-Administered Medication Market Size by Application (2019-2024)
6.3.2 North America Self-Administered Medication Market Size by Application (2025-2030)
6.3.3 North America Self-Administered Medication Market Share by Application (2019-2030)
6.4 North America Self-Administered Medication Market Size by Country
6.4.1 North America Self-Administered Medication Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Self-Administered Medication Market Size by Country (2019-2024)
6.4.3 North America Self-Administered Medication Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada

7 Europe
7.1 Europe Self-Administered Medication Market Size (2019-2030)
7.2 Europe Self-Administered Medication Market Size by Type
7.2.1 Europe Self-Administered Medication Market Size by Type (2019-2024)
7.2.2 Europe Self-Administered Medication Market Size by Type (2025-2030)
7.2.3 Europe Self-Administered Medication Market Share by Type (2019-2030)
7.3 Europe Self-Administered Medication Market Size by Application
7.3.1 Europe Self-Administered Medication Market Size by Application (2019-2024)
7.3.2 Europe Self-Administered Medication Market Size by Application (2025-2030)
7.3.3 Europe Self-Administered Medication Market Share by Application (2019-2030)
7.4 Europe Self-Administered Medication Market Size by Country
7.4.1 Europe Self-Administered Medication Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Self-Administered Medication Market Size by Country (2019-2024)
7.4.3 Europe Self-Administered Medication Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Self-Administered Medication Market Size (2019-2030)
8.2 China Self-Administered Medication Market Size by Type
8.2.1 China Self-Administered Medication Market Size by Type (2019-2024)
8.2.2 China Self-Administered Medication Market Size by Type (2025-2030)
8.2.3 China Self-Administered Medication Market Share by Type (2019-2030)
8.3 China Self-Administered Medication Market Size by Application
8.3.1 China Self-Administered Medication Market Size by Application (2019-2024)
8.3.2 China Self-Administered Medication Market Size by Application (2025-2030)
8.3.3 China Self-Administered Medication Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Self-Administered Medication Market Size (2019-2030)
9.2 Asia Self-Administered Medication Market Size by Type
9.2.1 Asia Self-Administered Medication Market Size by Type (2019-2024)
9.2.2 Asia Self-Administered Medication Market Size by Type (2025-2030)
9.2.3 Asia Self-Administered Medication Market Share by Type (2019-2030)
9.3 Asia Self-Administered Medication Market Size by Application
9.3.1 Asia Self-Administered Medication Market Size by Application (2019-2024)
9.3.2 Asia Self-Administered Medication Market Size by Application (2025-2030)
9.3.3 Asia Self-Administered Medication Market Share by Application (2019-2030)
9.4 Asia Self-Administered Medication Market Size by Region
9.4.1 Asia Self-Administered Medication Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Self-Administered Medication Market Size by Region (2019-2024)
9.4.3 Asia Self-Administered Medication Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Self-Administered Medication Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Type
10.2.1 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Self-Administered Medication Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Application
10.3.1 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Self-Administered Medication Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Country
10.4.1 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Self-Administered Medication Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Self-Administered Medication Introduction
11.1.4 Pfizer Revenue in Self-Administered Medication Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Self-Administered Medication Introduction
11.2.4 Abbott Laboratories Revenue in Self-Administered Medication Business (2019-2024)
11.2.5 Abbott Laboratories Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Self-Administered Medication Introduction
11.3.4 Novartis Revenue in Self-Administered Medication Business (2019-2024)
11.3.5 Novartis Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Self-Administered Medication Introduction
11.4.4 Sanofi Revenue in Self-Administered Medication Business (2019-2024)
11.4.5 Sanofi Recent Developments
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Self-Administered Medication Introduction
11.5.4 BD Revenue in Self-Administered Medication Business (2019-2024)
11.5.5 BD Recent Developments
11.6 Takeda Pharmaceutical
11.6.1 Takeda Pharmaceutical Company Details
11.6.2 Takeda Pharmaceutical Business Overview
11.6.3 Takeda Pharmaceutical Self-Administered Medication Introduction
11.6.4 Takeda Pharmaceutical Revenue in Self-Administered Medication Business (2019-2024)
11.6.5 Takeda Pharmaceutical Recent Developments
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Self-Administered Medication Introduction
11.7.4 Mylan Revenue in Self-Administered Medication Business (2019-2024)
11.7.5 Mylan Recent Developments
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Self-Administered Medication Introduction
11.8.4 Amgen Revenue in Self-Administered Medication Business (2019-2024)
11.8.5 Amgen Recent Developments
11.9 Antares Pharma
11.9.1 Antares Pharma Company Details
11.9.2 Antares Pharma Business Overview
11.9.3 Antares Pharma Self-Administered Medication Introduction
11.9.4 Antares Pharma Revenue in Self-Administered Medication Business (2019-2024)
11.9.5 Antares Pharma Recent Developments
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Details
11.10.2 Purdue Pharma Business Overview
11.10.3 Purdue Pharma Self-Administered Medication Introduction
11.10.4 Purdue Pharma Revenue in Self-Administered Medication Business (2019-2024)
11.10.5 Purdue Pharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Self-Administered Medication Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral
    Table 3. Key Players of Subcutaneous
    Table 4. Key Players of Nasal
    Table 5. Key Players of Transdermal
    Table 6. Key Players of Others
    Table 7. Global Self-Administered Medication Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Self-Administered Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Self-Administered Medication Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Self-Administered Medication Market Share by Region (2019-2024)
    Table 11. Global Self-Administered Medication Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Self-Administered Medication Market Share by Region (2025-2030)
    Table 13. Self-Administered Medication Market Trends
    Table 14. Self-Administered Medication Market Drivers
    Table 15. Self-Administered Medication Market Challenges
    Table 16. Self-Administered Medication Market Restraints
    Table 17. Global Self-Administered Medication Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Self-Administered Medication Revenue Share by Players (2019-2024)
    Table 19. Global Top Self-Administered Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-Administered Medication as of 2023)
    Table 20. Global Self-Administered Medication Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Self-Administered Medication Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Self-Administered Medication, Headquarters and Area Served
    Table 23. Global Key Players of Self-Administered Medication, Product and Application
    Table 24. Global Key Players of Self-Administered Medication, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Self-Administered Medication Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Self-Administered Medication Revenue Market Share by Type (2019-2024)
    Table 28. Global Self-Administered Medication Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Self-Administered Medication Revenue Market Share by Type (2025-2030)
    Table 30. Global Self-Administered Medication Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Self-Administered Medication Revenue Share by Application (2019-2024)
    Table 32. Global Self-Administered Medication Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Self-Administered Medication Revenue Share by Application (2025-2030)
    Table 34. North America Self-Administered Medication Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Self-Administered Medication Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Self-Administered Medication Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Self-Administered Medication Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Self-Administered Medication Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Self-Administered Medication Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Self-Administered Medication Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Self-Administered Medication Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Self-Administered Medication Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Self-Administered Medication Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Self-Administered Medication Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Self-Administered Medication Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Self-Administered Medication Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Self-Administered Medication Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Self-Administered Medication Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Self-Administered Medication Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Self-Administered Medication Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Self-Administered Medication Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Self-Administered Medication Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Self-Administered Medication Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Self-Administered Medication Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Self-Administered Medication Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Self-Administered Medication Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Self-Administered Medication Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Self-Administered Medication Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Self-Administered Medication Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Self-Administered Medication Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Self-Administered Medication Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Self-Administered Medication Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Self-Administered Medication Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Self-Administered Medication Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Self-Administered Medication Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Pfizer Company Details
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Self-Administered Medication Product
    Table 69. Pfizer Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 70. Pfizer Recent Developments
    Table 71. Abbott Laboratories Company Details
    Table 72. Abbott Laboratories Business Overview
    Table 73. Abbott Laboratories Self-Administered Medication Product
    Table 74. Abbott Laboratories Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 75. Abbott Laboratories Recent Developments
    Table 76. Novartis Company Details
    Table 77. Novartis Business Overview
    Table 78. Novartis Self-Administered Medication Product
    Table 79. Novartis Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 80. Novartis Recent Developments
    Table 81. Sanofi Company Details
    Table 82. Sanofi Business Overview
    Table 83. Sanofi Self-Administered Medication Product
    Table 84. Sanofi Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 85. Sanofi Recent Developments
    Table 86. BD Company Details
    Table 87. BD Business Overview
    Table 88. BD Self-Administered Medication Product
    Table 89. BD Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 90. BD Recent Developments
    Table 91. Takeda Pharmaceutical Company Details
    Table 92. Takeda Pharmaceutical Business Overview
    Table 93. Takeda Pharmaceutical Self-Administered Medication Product
    Table 94. Takeda Pharmaceutical Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 95. Takeda Pharmaceutical Recent Developments
    Table 96. Mylan Company Details
    Table 97. Mylan Business Overview
    Table 98. Mylan Self-Administered Medication Product
    Table 99. Mylan Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 100. Mylan Recent Developments
    Table 101. Amgen Company Details
    Table 102. Amgen Business Overview
    Table 103. Amgen Self-Administered Medication Product
    Table 104. Amgen Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 105. Amgen Recent Developments
    Table 106. Antares Pharma Company Details
    Table 107. Antares Pharma Business Overview
    Table 108. Antares Pharma Self-Administered Medication Product
    Table 109. Antares Pharma Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 110. Antares Pharma Recent Developments
    Table 111. Purdue Pharma Company Details
    Table 112. Purdue Pharma Business Overview
    Table 113. Purdue Pharma Self-Administered Medication Product
    Table 114. Purdue Pharma Revenue in Self-Administered Medication Business (2019-2024) & (US$ Million)
    Table 115. Purdue Pharma Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Self-Administered Medication Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Self-Administered Medication Market Share by Type: 2023 VS 2030
    Figure 3. Oral Features
    Figure 4. Subcutaneous Features
    Figure 5. Nasal Features
    Figure 6. Transdermal Features
    Figure 7. Others Features
    Figure 8. Global Self-Administered Medication Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Self-Administered Medication Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Pharmacies Case Studies
    Figure 11. Retail Pharmacies Case Studies
    Figure 12. Online Pharmacies Case Studies
    Figure 13. Self-Administered Medication Report Years Considered
    Figure 14. Global Self-Administered Medication Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Self-Administered Medication Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Self-Administered Medication Market Share by Region: 2023 VS 2030
    Figure 17. Global Self-Administered Medication Market Share by Players in 2023
    Figure 18. Global Top Self-Administered Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-Administered Medication as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Self-Administered Medication Revenue in 2023
    Figure 20. North America Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Self-Administered Medication Market Share by Type (2019-2030)
    Figure 22. North America Self-Administered Medication Market Share by Application (2019-2030)
    Figure 23. North America Self-Administered Medication Market Share by Country (2019-2030)
    Figure 24. United States Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Self-Administered Medication Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Self-Administered Medication Market Share by Type (2019-2030)
    Figure 28. Europe Self-Administered Medication Market Share by Application (2019-2030)
    Figure 29. Europe Self-Administered Medication Market Share by Country (2019-2030)
    Figure 30. Germany Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Self-Administered Medication Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Self-Administered Medication Market Share by Type (2019-2030)
    Figure 38. China Self-Administered Medication Market Share by Application (2019-2030)
    Figure 39. Asia Self-Administered Medication Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Self-Administered Medication Market Share by Type (2019-2030)
    Figure 41. Asia Self-Administered Medication Market Share by Application (2019-2030)
    Figure 42. Asia Self-Administered Medication Market Share by Region (2019-2030)
    Figure 43. Japan Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Self-Administered Medication Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Self-Administered Medication Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Self-Administered Medication Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Self-Administered Medication Market Share by Country (2019-2030)
    Figure 53. Brazil Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Self-Administered Medication Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Pfizer Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 61. Novartis Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 62. Sanofi Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 63. BD Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 65. Mylan Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 66. Amgen Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 67. Antares Pharma Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 68. Purdue Pharma Revenue Growth Rate in Self-Administered Medication Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)